Published in Surgery Litigation and Law Weekly, December 8th, 2006
The NexStent Carotid Stent is manufactured by EndoTex Interventional Systems, Inc., and has been distributed exclusively by Boston Scientific outside the U.S. since receiving European CE Mark in 2005. The company said it will acquire EndoTex within 90 days under the terms of the companies' existing agreements. The company said its FilterWire EZ Embolic Protection System, which was studied together with the NexStent Carotid Stent in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.